Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia
Seminars in Thrombosis and Hemostasis · 01.06.2026 · 52 (04) · 487-494
DOI: 10.1055/a-2570-4455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.06.2026. Verfasst von Marie Martin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team « Vascular Biology and Red Blood Cell » Université Claude Bernard Lyon…. Hauptthemen laut MEDLINE: Thrombelastography, Polycythemia, Blood Coagulation. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Thrombotic and cardiovascular events are among the leading causes of death for patients with polycythemia, more specifically for those with primary origin. It has been suggested that the high hematocrit (Hct) would favor hypercoagulability. However, the impact of Hct on coagulation in patients with polycythemia has not been investigated so far. The aim of our study was to compare the coagulation profiles of healthy subjects and patients with polycythemia and to evaluate the in vitro impact of Hct on coagulation. Blood from healthy individuals (n = 100 for blood viscosity; n = 19 for coagulation) and patients with primary/secondary polycythemia (n = 29 for blood viscosity; n = 20 for coagulation) was used to perform measurements at native Hct. The impact of Hct modulation (20% vs. 50%) on coagulation was tested in vitro in 9 healthy subjects and 19 patients with polycythemia. Blood viscosity was measured by viscosimetry and coagulation and fibrinolysis by rotational thromboelastometry. In patients with polycythemia, Hct, and blood viscosity were higher, clotting time was prolonged and clot lysis was faster compared to healthy individuals. Our in vitro results showed that the clotting time was faster and the clot firmness higher at 20% versus 50% Hct for both populations, without any difference between the two populations at a given Hct. Our findings suggest that the interpretation of thromboelastometry results should be approached with caution in patients with high Hct. The in vivo hypercoagulable state of patients with polycythemia is probably the consequence of changes in hemodynamic conditions attributed to blood hyper-viscosity, that may promote venous stasis and platelet margination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team « Vascular Biology and Red Blood Cell » Université Claude Bernard Lyon 1, Université de Lyon, Lyon, France.
- Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France.
- Service d'hématologie-hémostase, Hospices civils de Lyon, Bron, France.
- EA 4609-Hémostase et Cancer, SFR Lyon Est, Université Claude Bernard Lyon I, Lyon, France.
- Laboratoire de Biochimie et de Biologie Moléculaire, UF de Biochimie des Pathologies Erythrocytaires, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, Bron, France.
- Service d'hématologie Lyon Sud, Hospices Civils de Lyon, Lyon, France.
Zitieren
APA
Martin, M., Nader, E., Rezigue, H., Dargaud, Y., Renoux, C., Joly, P., Heiblig, M., Nougier, C., & Connes, P. (2026). Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia. Seminars in Thrombosis and Hemostasis, 52(04), 487-494. https://doi.org/10.1055/a-2570-4455
Vancouver
Martin M, Nader E, Rezigue H, Dargaud Y, Renoux C, Joly P, et al. Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia. Seminars in Thrombosis and Hemostasis. 2026;52(04):487-494. doi:10.1055/a-2570-4455
BibTeX
@article{Martin2026,
author = {Martin, Marie and Nader, Elie and Rezigue, Hamdi and Dargaud, Yesim and Renoux, Céline and Joly, Philippe and Heiblig, Mael and Nougier, Christophe and Connes, Philippe},
title = {Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2026},
volume = {52},
number = {04},
pages = {487--494},
doi = {10.1055/a-2570-4455}
}
EUVIMED